New Medicare items to help investigate prostate cancer
1 July 2022
Today we welcome the introduction of two new PET/PSMA Medicare items, for the investigation of prostate cancer.
Australia has one of the highest rates of prostate cancer in the world, with one in every six Australian men likely to be diagnosed by age 85.
These items allow patients to access imaging that provides far greater sensitivity and specificity when compared to conventional imaging.
Great news for thousands of Australian men (and their families) who are at risk of prostate cancer or are currently living with the disease.
PET/PSMA scans are available at our City West clinic and are bulk billed.